[Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)].
K Credner, M Tauscher, L Jozić, G Brenner
Index: Arzneimittelforschung 31(12) , 2096-100, (1981)
Full Text: HTML
Abstract
5-Methylpyrazole-3-carboxylic acid forms salts with basically substituted adenine bases of type (4) or (5), which have significantly more lipolysis inhibitory activity than the free acid itself. The substance tested, 6-amino-9-[2-hydroxy-3-(N-methyl-N-2-hydroxyethyl)-aminopropyl]-purine-5-methyl pyrazole-3-carboxylate (16), causes a significant reduction of serum FFA levels in fasted rats, even at the very low dosage of 0.150 mg/kg b.w., whereas the free 5-methylpyrazole-3-carboxylic-acid shows significant activity in this model only at doses of 2 mg/kg b.w. and above. The salt also shows similar activity on serum triglycerides. The effect on FFA, triglyceride and cholesterol levels, respectively, in fasted rats lasts for at least 8 h.
Related Compounds
Related Articles:
2010-11-01
[Chirality 22 , 901-916, (2010)]
2011-01-01
[J. Pharmacol. Exp. Ther. 336 , 282-293, (2011)]
2008-03-01
[Eur. Neuropsychopharmacol. 18(3) , 200-14, (2008)]
Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.
1982-11-01
[Diabetes 31(11) , 994-1001, (1982)]
2009-12-01
[Biochem. Pharmacol. 78(11) , 1360-5, (2009)]